Concepedia

Author

Rajlakshmi Devi

Institute of Advanced Study in Science and TechnologyORCID

Also Known As

R. Devi, R.Bhavani Devi,, Rajlakshmi Devi, Rupa Devi

15

Publications

379

Citations

9

H-Index

23

Concepts

All Affiliations

Institute of Advanced Study in Science and TechnologyAnnamalai UniversityIndian Institute of Technology Guwahati
RD

About

Rajlakshmi Devi is an author at Institute of Advanced Study in Science and Technology specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

167

2

Biochemistry

2

2

91

3

Health Sciences

1

1

42

4

Natural Sciences

1

1

30

5

Diabetes

1

1

42

Rajlakshmi Devi

×

9

Publications

371

Citations

9

H-Index

YearCitations

In vitro and In vivo Antioxidant, Anti-hyperlipidemic Properties and Chemical Characterization of Centella asiatica (L.) Extract

Sima Kumari, Meetali Deori, R. Elancheran,

Frontiers in Pharmacology

2016

96

Rapid screening and identification of phenolic antioxidants in Hydrocotyle sibthorpioides Lam. by UPLC–ESI-MS/MS

Sima Kumari, R. Elancheran, Jibon Kotoky,

Food Chemistry

2016

61

Phytochemical screening, antioxidant, antityrosinase, and antigenotoxic potential of Amaranthus viridis extract

Rajlakshmi Devi, Sima Kumari, R. Elancheran

Indian Journal of Pharmacology

2018

45

Polyphenol Rich Extract of Garcinia pedunculata Fruit Attenuates the Hyperlipidemia Induced by High Fat Diet

Rahul Sarma, Sima Kumari, R. Elancheran,

Frontiers in Pharmacology

2016

42

<i>Musa balbisiana</i> Fruit Rich in Polyphenols Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats via Inhibition of Inflammation and Oxidative Stress

Sima Kumari, Parmeshwar B. Katare, R. Elancheran,

Oxidative Medicine and Cellular Longevity

2020

36

Design and development of oxobenzimidazoles as novel androgen receptor antagonists

R. Elancheran, K. Saravanan, Bhaswati Choudhury,

Medicinal Chemistry Research

2016

30

Design, Synthesis and Biological Evaluation of Novel 1, 3- thiazolidine-2, 4-diones as Anti-prostate Cancer Agents

R. Elancheran, Kuppusamy Saravanan, S. Divakar,

Anti-Cancer Agents in Medicinal Chemistry

2018

27

Recent discoveries and developments of androgen receptor based therapy for prostate cancer

R. Elancheran, V.L. Maruthanila, Meena Ramanathan,

MedChemComm

2015

19

Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway

S. Divakar, K. Saravanan, P. Karthikeyan,

Chemico-Biological Interactions

2017

15

Page 1